Dhanuka Agritech Gelecekteki Büyüme
Future kriter kontrolleri 2/6
Dhanuka Agritech kazanç ve gelirin sırasıyla yıllık 10.5% ve 11.5% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 10.2% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 17.2% olacağı tahmin edilmektedir.
Anahtar bilgiler
10.5%
Kazanç büyüme oranı
10.17%
EPS büyüme oranı
| Chemicals kazanç büyümesi | 19.5% |
| Gelir büyüme oranı | 11.5% |
| Gelecekteki özkaynak getirisi | 17.16% |
| Analist kapsamı | Good |
| Son güncelleme | 21 May 2026 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Anlatı Güncellemesi • May 03
507717: Upcoming Director Appointment Will Support Future Upside Confidence
Analysts have nudged their price target on Dhanuka Agritech slightly higher, with fair value moving from ₹1,426.00 to about ₹1,439.57, citing updated assumptions around the discount rate, revenue growth, profit margins and future P/E. What's in the News A postal ballot based Special or Extraordinary Shareholders Meeting is scheduled for March 19, 2026, in India (Key Developments).Anlatı Güncellemesi • Apr 18
507717: Upcoming Governance And Earnings Dates Will Support Future Upside Confidence
Analysts have trimmed their price target on Dhanuka Agritech slightly from ₹1,438.50 to ₹1,426.00, reflecting updated assumptions around the discount rate, revenue growth, profit margin, and forward P/E. What's in the News Special or Extraordinary Shareholders Meeting scheduled via postal ballot in India on Mar 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an Independent Director for a first term of 5 years (company filing).Anlatı Güncellemesi • Apr 03
507717: Upcoming Governance And Earnings Dates Will Support Upside Confidence
Analysts have kept their price target for Dhanuka Agritech steady at around ₹1,438, reflecting largely unchanged views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Dhanuka Agritech has scheduled a Special or Extraordinary Shareholders Meeting via postal ballot in India on March 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an Independent Director for a first term of 5 years (Key Developments).Anlatı Güncellemesi • Mar 19
507717: Upcoming Meetings Will Reinforce Confidence In Sustained Upside Potential
Analysts have kept the price target for Dhanuka Agritech broadly steady at around ₹1,438, with only minor model tweaks to the discount rate and the assumed future P/E driving the small change. What's in the News A Special or Extraordinary shareholders meeting is scheduled via postal ballot in India on Mar 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an independent director for a first term of 5 years (company filing).Anlatı Güncellemesi • Mar 05
507717: Upcoming Meetings Will Support Confidence In Long-Term Upside Potential
Analysts have maintained their ₹1,438.50 price target for Dhanuka Agritech and made only minor adjustments to their assumptions on discount rate, revenue growth, profit margin and future P/E. These limited changes suggest that their overall valuation framework remains broadly consistent with earlier assessments.
Yeni Anlatı • Feb 21
Rural Distribution And Biostimulant Tailwinds Will Support A Stronger Long Term Outlook
Catalysts About Dhanuka Agritech Dhanuka Agritech is an Indian agrochemical company supplying crop protection and allied products to farmers across major agricultural regions in India. What are the underlying business or industry changes driving this perspective?Anlatı Güncellemesi • Feb 19
507717: Upcoming Board And Shareholder Meetings Will Support Long-Term Upside Potential
Analysts have revised their price target on Dhanuka Agritech from ₹1,571.75 to ₹1,438.50, reflecting updated assumptions around the discount rate, expected revenue growth, profit margin and future P/E multiples. What's in the News Dhanuka Agritech has scheduled a Board Meeting on Feb 05, 2026, at 13:00 Indian Standard Time to consider and approve the financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).
Yeni Anlatı • Feb 06
Dahej Ramp Up Risks And Regulatory Setbacks Will Eventually Support A Stronger Business
Catalysts About Dhanuka Agritech Dhanuka Agritech is an Indian agrochemical company supplying crop protection products and related offerings to farmers across major agricultural regions. What are the underlying business or industry changes driving this perspective?Anlatı Güncellemesi • Feb 04
507717: Stable Assumptions And Upcoming Results Will Support Long-Term Upside Potential
Analysts have kept their price target for Dhanuka Agritech unchanged at ₹1,571.75, citing broadly consistent assumptions for the discount rate, revenue growth, profit margin and future P/E in their refreshed model. What's in the News Dhanuka Agritech has scheduled a board meeting on Feb 05, 2026.Anlatı Güncellemesi • Jan 21
507717: Higher Margin Outlook Will Support Long-Term Upside Potential
Analysts have trimmed their price target for Dhanuka Agritech by ₹35 to ₹1,571.75. This reflects updated views on slightly lower revenue growth assumptions, a modestly higher discount rate, and a small adjustment to future P/E expectations, partly offset by a marginally higher profit margin outlook.Anlatı Güncellemesi • Jan 06
507717: Nagpur Plant Land Purchase Will Support Long-Term Upside Potential
Analysts have kept their price target for Dhanuka Agritech unchanged at ₹1,606.75, with only minor tweaks to inputs such as the discount rate, revenue growth, profit margin, and future P/E assumptions guiding their view. What's in the News Board meeting scheduled on Oct 31, 2025 at 11:00 Indian Standard Time to review and approve financial results for the quarter and half year ended Sep 30, 2025 (company filing).Anlatı Güncellemesi • Dec 16
507717: Nagpur Formulation Plant Expansion Will Drive Long-Term Upside Potential
Analysts have nudged their fair value estimate for Dhanuka Agritech down slightly from ₹1,638 to about ₹1,607 per share, reflecting tempered revenue growth expectations, partially offset by a modestly higher projected profit margin and a slightly lower assumed future P E multiple. What's in the News Board meeting scheduled on October 31, 2025, at 11:00 IST to review financial results for the quarter and half year ended September 30, 2025 (company filing) Board to consider purchase of land in Nagpur, Maharashtra, for setting up a new formulation plant, indicating planned capacity expansion (company filing) Outcome of the October 31, 2025 board meeting expected to provide clarity on near term growth, capex, and margin trajectory (company filing) Valuation Changes The fair value estimate was reduced slightly from ₹1,638 to about ₹1,607 per share, reflecting marginally softer assumptions.Anlatı Güncellemesi • Dec 02
507717: Upcoming Nagpur Plant And Board Actions Will Fuel Long-Term Momentum
Analysts have maintained their fair value estimate for Dhanuka Agritech at ₹1,638, citing stable projections for growth and profitability despite minor adjustments in underlying assumptions. What's in the News Dhanuka Agritech will hold a Board Meeting on October 31, 2025, at 11:00 Indian Standard Time (Board Meeting announcement).Anlatı Güncellemesi • Nov 17
507717: New Formulation Plant Decision Will Drive Next Wave Of Expansion
Analysts have lowered their price target for Dhanuka Agritech from ₹1,779.88 to ₹1,638.00. This reflects tempered expectations for future revenue growth and profit margins.Anlatı Güncellemesi • Nov 03
507717: New Nagpur Plant And Higher Margins Will Drive Future Upside
Analysts have revised their price target for Dhanuka Agritech downward from ₹1,875 to ₹1,779.88. This adjustment reflects updated projections in revenue growth and profit margins, as well as a slightly reduced future valuation multiple.Anlatı Güncellemesi • Sep 05
Improved Monsoon Trends And Capacity Expansion Will Drive Agrochemicals Demand
With both the discount rate and future P/E essentially unchanged, analysts maintained Dhanuka Agritech’s fair value at ₹1875. What's in the News Board meeting scheduled to consider and approve financial results for the quarter ended 30 June, 2025.
Yeni Anlatı • Feb 09
Acquiring Rights To Iprovalicarb And Triadimenol Will Open International Markets
International expansion and product innovation could boost revenue through new market entry, geographic diversification, and premium pricing for unique solutions.Kazanç ve Gelir Büyüme Tahminleri
| Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
|---|---|---|---|---|---|
| 3/31/2028 | 25,956 | 3,538 | 2,533 | 3,172 | 6 |
| 3/31/2027 | 22,991 | 3,065 | 1,969 | 2,752 | 4 |
| 3/31/2026 | 20,628 | 2,872 | 1,685 | 1,962 | N/A |
| 12/31/2025 | 19,785 | 2,650 | N/A | N/A | N/A |
| 9/30/2025 | 20,138 | 2,800 | 714 | 2,663 | N/A |
| 6/30/2025 | 20,699 | 3,036 | N/A | N/A | N/A |
| 3/31/2025 | 20,352 | 2,970 | 687 | 2,627 | N/A |
| 12/31/2024 | 19,614 | 2,805 | N/A | N/A | N/A |
| 9/30/2024 | 19,194 | 2,708 | 985 | 1,431 | N/A |
| 6/30/2024 | 18,831 | 2,550 | N/A | N/A | N/A |
| 3/31/2024 | 17,585 | 2,391 | 451 | 1,345 | N/A |
| 12/31/2023 | 17,615 | 2,454 | N/A | N/A | N/A |
| 9/30/2023 | 17,516 | 2,461 | 1,061 | 2,317 | N/A |
| 6/30/2023 | 16,766 | 2,173 | N/A | N/A | N/A |
| 3/31/2023 | 17,002 | 2,335 | 120 | 1,362 | N/A |
| 12/31/2022 | 16,473 | 2,226 | N/A | N/A | N/A |
| 9/30/2022 | 16,108 | 2,191 | -640 | 331 | N/A |
| 6/30/2022 | 15,067 | 2,094 | N/A | N/A | N/A |
| 3/31/2022 | 14,778 | 2,089 | 445 | 1,043 | N/A |
| 12/31/2021 | 14,350 | 2,031 | N/A | N/A | N/A |
| 9/30/2021 | 13,738 | 2,007 | 792 | 1,038 | N/A |
| 6/30/2021 | 13,774 | 2,074 | N/A | N/A | N/A |
| 3/31/2021 | 13,875 | 2,106 | 2,184 | 2,311 | N/A |
| 12/31/2020 | 13,395 | 2,009 | N/A | N/A | N/A |
| 9/30/2020 | 13,153 | 1,886 | 2,589 | 2,726 | N/A |
| 6/30/2020 | 12,749 | 1,785 | N/A | N/A | N/A |
| 3/31/2020 | 11,201 | 1,413 | 1,484 | 1,621 | N/A |
| 12/31/2019 | 10,852 | 1,291 | N/A | N/A | N/A |
| 9/30/2019 | 10,305 | 1,160 | N/A | 627 | N/A |
| 6/30/2019 | 10,118 | 1,111 | N/A | N/A | N/A |
| 3/31/2019 | 10,058 | 1,126 | N/A | 133 | N/A |
| 12/31/2018 | 9,982 | 1,145 | N/A | N/A | N/A |
| 9/30/2018 | 10,029 | 1,285 | N/A | N/A | N/A |
| 6/30/2018 | 9,676 | 1,262 | N/A | N/A | N/A |
| 3/31/2018 | 9,626 | 1,262 | N/A | 1,377 | N/A |
| 12/31/2017 | 9,265 | 1,201 | N/A | N/A | N/A |
| 9/30/2017 | 9,168 | 1,183 | N/A | N/A | N/A |
| 6/30/2017 | 8,812 | 1,156 | N/A | N/A | N/A |
| 3/31/2017 | 8,833 | 1,219 | N/A | 631 | N/A |
| 12/31/2016 | 8,886 | 1,237 | N/A | N/A | N/A |
| 9/30/2016 | 8,857 | 1,196 | N/A | N/A | N/A |
| 6/30/2016 | 8,469 | 1,081 | N/A | N/A | N/A |
| 3/31/2016 | 8,289 | 1,073 | N/A | 1,397 | N/A |
| 12/31/2015 | 8,116 | 1,007 | N/A | N/A | N/A |
| 9/30/2015 | 7,850 | 1,002 | N/A | N/A | N/A |
| 6/30/2015 | 7,977 | 1,042 | N/A | N/A | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: 507717 'nin tahmini kazanç büyümesi (yıllık 10.5% ) tasarruf oranının ( 6.9% ) üzerindedir.
Kazançlar ve Piyasa: 507717 şirketinin kazançlarının (yıllık 10.5% ) Indian pazarından (yıllık 16.3% ) daha yavaş büyümesi öngörülüyor.
Yüksek Büyüme Kazançları: 507717 şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.
Gelir ve Pazar: 507717 şirketinin gelirinin (yıllık 11.5% ) Indian pazarından (yıllık 10.8% ) daha hızlı büyümesi öngörülüyor.
Yüksek Büyüme Geliri: 507717 şirketinin gelirinin (yıllık 11.5% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: 507717 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 17.2 %).
Büyüyen şirketleri keşfedin
Şirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/05/21 09:06 |
| Gün Sonu Hisse Fiyatı | 2026/05/21 00:00 |
| Kazançlar | 2026/03/31 |
| Yıllık Kazançlar | 2026/03/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
Dhanuka Agritech Limited 17 Bu analistlerden 6, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| null null | 360 ONE Capital Market Private Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Himanshu Binani | Anand Rathi Shares and Stock Brokers Limited |